Search results for "Phoma"

showing 10 items of 716 documents

Whole-body magnetic resonance imaging and FDG-PET/CT for lymphoma staging: Assessment of patient experience

2017

Purpose: To compare patient experience of whole-body MRI and FDG-PET/CT performed for lymphoma staging. Methods: One-hundred-fifteen patients (59 males, 56 females; 53 Hodgkin, 62 non-Hodgkin; mean age: 43.8 years) with lymphoma underwent whole-body MRI and FDG-PET/CT for staging and filled a questionnaire regarding their experience of the examinations using a 4-point Likert scale (1, very good; 4,very bad). Differences were evaluated using Wilcoxon signed-rank test. Patients were asked to express their preference on both techniques. Preferences were compared on the basis of gender, age, and Ann Arbor stage using the chi-square test. A p-value ≤ .05 was considered significant. Results: Most…

Patient experiencelcsh:Medical physics. Medical radiology. Nuclear medicinemedicine.medical_specialtyLymphomaWilcoxon signed-rank testlcsh:R895-920Whole body imagingLymphoma staging030218 nuclear medicine & medical imaging03 medical and health sciencesMagnetic resonance imaging0302 clinical medicinePatient experiencemedicineRadiology Nuclear Medicine and imagingStage (cooking)Whole body imagingmedicine.diagnostic_testbusiness.industryMagnetic resonance imagingmedicine.diseaseLymphomaPositron emission tomography030220 oncology & carcinogenesisRadiologyPositron-emission tomographybusinessThe Egyptian Journal of Radiology and Nuclear Medicine
researchProduct

Patient with Kabuki syndrome and acute leukemia

2003

Kabuki syndrome is a multiple congenital anomaly/mental retardation syndrome which often involves recurrent infections. There is cumulative evidence of an immunodeficiency in Kabuki patients. We report a 2-year-old girl with typical Kabuki syndrome, who developed acute lymphocytic leukemia. The patient showed low levels of immunoglobulins G and A and a history of recurrent infections, that might indicate an immunodeficiency leading to an increased susceptibility to cancer. The girl was treated according to BFM protocols adapted to the patient's impaired cardiac situation and severe underweight. She achieved continual complete remission. Classical and molecular cytogenetic analyzes did not d…

Pediatricsmedicine.medical_specialtyAcute leukemiabusiness.industryKabukiInfantCancerPrecursor Cell Lymphoblastic Leukemia-Lymphomamedicine.diseaseIntellectual DisabilityImmunopathologyAcute lymphocytic leukemiaImmunologymedicineHumansAbnormalities MultipleFemaleAbnormalitybusinessKabuki syndromeGenetics (clinical)ImmunodeficiencyAmerican Journal of Medical Genetics
researchProduct

Burkitt’s lymphoma in pregnant woman: Difficult management of a rare case

2020

Highlights • Burkitt’s lymphoma, an aggressive non-Hodgkin lymphoma, is extremely rare during pregnancy. • Lymphoma of the small intestine is often overlooked in the early stages of the disease. • We described a multidisciplinary approach, cesarean section with surgical intestinal exploration.

Pediatricsmedicine.medical_specialtyBurkitt’s lymphomaIntestinal involvementNauseaCase ReportDisease03 medical and health sciences0302 clinical medicineimmune system diseasesPregnancyhemic and lymphatic diseasesmedicineNon-Hodgkin lymphomaPregnancyBurkitt's lymphomabusiness.industryGestational agemedicine.diseaseLymphoma030220 oncology & carcinogenesisVomitingGestation030211 gastroenterology & hepatologySurgerymedicine.symptombusinessBurkitt's lymphomaInternational Journal of Surgery Case Reports
researchProduct

Post-transplant lymphoproliferative disorder in adult renal transplant recipients: case series and review of literature

2021

Post-transplant lymphoproliferative disorder (PTLD) is serious life-threating complication of transplantation. The clinical picture differs from lymphomas observed in the general population, with different manifestation, histopathology, higher aggressiveness with involvement of sites beyond the primary lymph node, and poorer outcome. The objective of the study was to present nine cases of PTLD observed in our centre among the kidney transplant recipient population and discuss the results with up-to-date literature. We performed a retrospective single-centre assessment of PTLD incidence in the cohorts of kidney transplant recipients followed by our centre. We found nine cases of PTLD, five m…

Pediatricsmedicine.medical_specialtyImmunologyPopulationkidney transplantationCase ReportlymphomaPost-transplant lymphoproliferative disorderhemic and lymphatic diseasesImmunology and AllergyMedicineeducationKidney transplantationeducation.field_of_studybusiness.industryIncidence (epidemiology)Rmedicine.diseaseLymphomaTransplantationsurgical procedures operativekidney transplantation.post-transplant lymphoproliferative diseaseMedicinebusinessComplicationRare diseaseCentral European Journal of Immunology
researchProduct

Identification of pyrrolo[3',4':3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas

2023

Unsatisfactory outcomes for relapsed/refractory lymphoma patients prompt continuing efforts to develop new therapeutic strategies. Our previous studies on pyrrole-based anti-lymphoma agents led us to synthesize a new series of twenty-six pyrrolo[3′,4':3,4]cyclohepta[1,2-d] [1,2]oxazole derivatives and study their antiproliferative effects against a panel of four non-Hodgkin lymphoma cell lines. Several candidates showed significant anti-proliferative effects, with IC50's reaching the sub-micromolar range in at least one cell line, with compound 3z demonstrating sub-micromolar growth inhibitory effects towards the entire panel. The VL51 cell line was the most sensitive, with an IC50 value of…

Pharmacology2-d][1Antitumor agentsLymphoma4’:3Organic ChemistryGeneral MedicineIsoxazolespyrrolo[3′2]oxazolesHematological malignanciesAntitumor agents; Hematological malignancies; Isoxazoles; Lymphoma; pyrrolo[3′4’:34]cyclohepta[12-d][12]oxazolespyrrolo[3′4’:34]cyclohepta[12-d][12]oxazoles4]cyclohepta[1Drug Discovery
researchProduct

Development of [1,2]oxazoloisoindoles tubulin polymerization inhibitors: Further chemical modifications and potential therapeutic effects against lym…

2022

Lymphomas are among the ten most common cancers, and, although progress has been achieved in increasing survival, there is still an unmet need for more effective therapeutic approaches, including better options for patients with refractory tumors that initially respond but then relapse. The lack of effective alternative treatment options highlights the need to develop new therapeutic strategies capable of improving survival prospects for lymphoma patients. Herein, we describe the identification and exploration of the SAR of a series of [1,2]oxazolo[5,4-e]isoindoles as potent small molecules that bind to the colchicine site of tubulin and that have promise for the treatment of refractory lym…

PharmacologyBinding SitesLymphomaAntitubulin agentsColchicine siteOrganic ChemistryAntineoplastic AgentsGeneral MedicineIsoindolesTubulin ModulatorsT2R-TTL–ComplexesStructure-Activity RelationshipTubulinNeoplasmsCell Line TumorDrug DiscoveryHumans[12]oxazolo[54-e]isoindolesColchicineX-ray crystallographyEuropean Journal of Medicinal Chemistry
researchProduct

Indole alkaloids from the coprophilous fungus Aphanoascus fulvescens

2019

Abstract The Ascomycete fungus Aphanoascus fulvescens isolated from goose dung was investigated for its secondary metabolites, yielding five new indole alkaloids okaramines V–Z (1–5) and eleven known derivatives (6–16). Their structures were determined by 1D, 2D NMR spectra and HRMS data. Compounds 6, 8, 11 and 12 showed significant to moderate cytotoxicity against the mouse lymphoma cell line L5178Y with IC50 values ranging from 4.0 to 14.7 μM. Preliminary structure-activity relationships are discussed.

PharmacologyIndole testbiology010405 organic chemistryChemistryStereochemistryMouse LymphomaGeneral MedicineFungusAphanoascus fulvescensbiology.organism_classification01 natural sciences0104 chemical sciences010404 medicinal & biomolecular chemistryGoosebiology.animalDrug DiscoveryIc50 valuesCytotoxicityTwo-dimensional nuclear magnetic resonance spectroscopyFitoterapia
researchProduct

Aaptamine Derivatives from the Indonesian Sponge Aaptos suberitoides

2013

Four new aaptamine derivatives (1-4) along with aaptamine (5) and three related compounds (6-8) were isolated from the ethanol extract of the sponge Aaptos suberitoides collected in Indonesia. The structures of the new compounds were unambiguously determined by one- and two-dimensional NMR and by HRESIMS measurements. Compounds 3, 5, and 6 showed cytotoxic activity against the murine lymphoma L5178Y cell line, with IC(50) values ranging from 0.9 to 8.3 μM.

PharmacologyMolecular StructurebiologyMurine lymphomaStereochemistryOrganic ChemistryPharmaceutical ScienceAntineoplastic AgentsAaptos suberitoidesbiology.organism_classificationPoriferaAnalytical ChemistryInhibitory Concentration 50MiceSpongeComplementary and alternative medicineIndonesiaDrug DiscoveryAnimalsHumansMolecular MedicineInhibitory concentration 50Drug Screening Assays AntitumorNaphthyridinesNuclear Magnetic Resonance BiomolecularJournal of Natural Products
researchProduct

Ircinal E, a New Manzamine Derivative from the Indonesian Marine Sponge Acanthostrongylophora ingens

2015

Chemical investigation of the MeOH extract of the sponge Acanthostrongylophora ingens afforded the new manzamine derivative ircinal E (1), in addition to six known metabolites (2–7). The structure of the new compound was unequivocally elucidated using one- and two-dimensional NMR spectroscopy, as well as high-resolution mass spectrometry. Compounds 1–6 exhibited strong to moderate cytotoxicity against the murine lymphoma L5178Y cell line with IC50 values ranging from 2.8 to 21.7 μM.

PharmacologyMurine lymphomabiologyStereochemistryAcanthostrongylophora ingensPlant ScienceGeneral MedicineNuclear magnetic resonance spectroscopybiology.organism_classificationMass spectrometrySpongechemistry.chemical_compoundComplementary and alternative medicinechemistryDrug DiscoveryBotanyMoleculeCytotoxicityDerivative (chemistry)Natural Product Communications
researchProduct

Metabolites from Combretum dolichopetalum and its associated endophytic fungus Nigrospora oryzae--Evidence for a metabolic partnership.

2015

Abstract A new altersolanol derivative, 4-dehydroxyaltersolanol A ( 9 ), along with two known sesquiterpenoids, ( S )-7′-hydroxyabscisic acid ( 7 ) and ( S )-abscisic acid ( 8 ) were obtained from the endophytic fungus, Nigrospora oryzae , isolated from leaves of Combretum dolichopetalum . The host plant yielded six known compounds including ellagic acid ( 1 ), 3, 3′, 4-tri-O-methylellagic acid ( 2 ), arjunolic acid ( 3 ), 4′-dihydrophaseic acid ( 4 ), echinulin ( 5 ) and arestrictin B ( 6 ). Close structural similarities with regard to compounds 4 , 7 and 8 were observed between the metabolites from the host plant and those of the endophytic fungus. Furthermore compounds 5 and 6 are relate…

PharmacologybiologyMolecular StructureStereochemistryMouse LymphomaCombretumAnthraquinonesGeneral MedicineEndophytic fungusbiology.organism_classificationPlant Leaveschemistry.chemical_compoundMicechemistryAscomycotaCell Line TumorDrug DiscoveryEndophytesAnimalsCombretumArestrictin BNigrospora oryzaeCytotoxicityTwo-dimensional nuclear magnetic resonance spectroscopyEllagic acidFitoterapia
researchProduct